273 related articles for article (PubMed ID: 22539846)
1. Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.
Groman SM; Lee B; Seu E; James AS; Feiler K; Mandelkern MA; London ED; Jentsch JD
J Neurosci; 2012 Apr; 32(17):5843-52. PubMed ID: 22539846
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control.
Groman SM; Morales AM; Lee B; London ED; Jentsch JD
Psychopharmacology (Berl); 2013 Oct; 229(3):527-38. PubMed ID: 23748383
[TBL] [Abstract][Full Text] [Related]
3. Positive and negative feedback learning and associated dopamine and serotonin transporter binding after methamphetamine.
Stolyarova A; O'Dell SJ; Marshall JF; Izquierdo A
Behav Brain Res; 2014 Sep; 271():195-202. PubMed ID: 24959862
[TBL] [Abstract][Full Text] [Related]
4. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
5. Comparison of single-dose and extended methamphetamine administration on reversal learning in rats.
Kosheleff AR; Rodriguez D; O'Dell SJ; Marshall JF; Izquierdo A
Psychopharmacology (Berl); 2012 Dec; 224(3):459-67. PubMed ID: 22760483
[TBL] [Abstract][Full Text] [Related]
6. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
Melega WP; Jorgensen MJ; Laćan G; Way BM; Pham J; Morton G; Cho AK; Fairbanks LA
Neuropsychopharmacology; 2008 May; 33(6):1441-52. PubMed ID: 17625500
[TBL] [Abstract][Full Text] [Related]
7. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.
Schwendt M; Rocha A; See RE; Pacchioni AM; McGinty JF; Kalivas PW
J Pharmacol Exp Ther; 2009 Nov; 331(2):555-62. PubMed ID: 19648469
[TBL] [Abstract][Full Text] [Related]
8. Changes in neural circuitry regulating response-reversal learning and Arc-mediated consolidation of learning in rats with methamphetamine-induced partial monoamine loss.
Pastuzyn ED; Keefe KA
Neuropsychopharmacology; 2014 Mar; 39(4):963-72. PubMed ID: 24150570
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys.
Lee B; Groman S; London ED; Jentsch JD
Neuropsychopharmacology; 2007 Oct; 32(10):2125-34. PubMed ID: 17299511
[TBL] [Abstract][Full Text] [Related]
10. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Psychopharmacology (Berl); 2005 Jul; 180(3):501-12. PubMed ID: 15959831
[TBL] [Abstract][Full Text] [Related]
11. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
[TBL] [Abstract][Full Text] [Related]
12. Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine.
Izquierdo A; Belcher AM; Scott L; Cazares VA; Chen J; O'Dell SJ; Malvaez M; Wu T; Marshall JF
Neuropsychopharmacology; 2010 Jan; 35(2):505-14. PubMed ID: 19794407
[TBL] [Abstract][Full Text] [Related]
13. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
Ashok AH; Mizuno Y; Volkow ND; Howes OD
JAMA Psychiatry; 2017 May; 74(5):511-519. PubMed ID: 28297025
[TBL] [Abstract][Full Text] [Related]
14. A history of ethanol drinking increases locomotor stimulation and blunts enhancement of dendritic dopamine transmission by methamphetamine.
Tschumi CW; Daszkowski AW; Sharpe AL; Trzeciak M; Beckstead MJ
Addict Biol; 2020 Jul; 25(4):e12763. PubMed ID: 31062485
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice.
Qi J; Yang JY; Song M; Li Y; Wang F; Wu CF
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):441-8. PubMed ID: 18092152
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.
Schweppe CA; Burzynski C; Jayanthi S; Ladenheim B; Cadet JL; Gardner EL; Xi ZX; van Praag H; Newman AH; Keck TM
Psychopharmacology (Berl); 2020 Jul; 237(7):1989-2005. PubMed ID: 32388619
[TBL] [Abstract][Full Text] [Related]
17. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.
Proebstl L; Kamp F; Manz K; Krause D; Adorjan K; Pogarell O; Koller G; Soyka M; Falkai P; Kambeitz J
Eur Psychiatry; 2019 Jun; 59():15-24. PubMed ID: 30981746
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S
Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305
[TBL] [Abstract][Full Text] [Related]
19. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.
London ED
Adv Pharmacol; 2016; 76():67-84. PubMed ID: 27288074
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
